Engineered probiotic developed to treat multiple sclerosis

Researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham health care system, have designed a probiotic to suppress autoimmunity in the brain, which occurs when the immune system attacks the cells of the central nervous system. Autoimmunity in the brain is at the core of several diseases, including multiple sclerosis (MS).